SCHEMBL340364

SCHEMBL340364

CCOC(=O)c1cccc(O)c1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.67
CA1 P00915 3/20 0.67
CA2 P00918 3/20 0.67
CA7 P43166 3/20 0.67
CA9 Q16790 3/20 0.67
CA14 Q9ULX7 3/20 0.67
TSHR P16473 1/20 0.66
CDC25B P30305 2/20 0.56
ALDH1A1 P00352 2/20 0.56
HSD17B10 Q99714 1/20 0.56
MAPT P10636 4/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
CYP1A2 P05177 2/20 0.51
MEN1 O00255 1/20 0.51
USP2 O75604 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10571657 0.90 TSHR (0.73) CA12CA1CA2CA7CA9
SCHEMBL639072 0.87 ALDH1A1 (0.61) CA12CA1CA2CA7CA9
SCHEMBL30960327 0.86 TSHR (0.65) CA12CA1CA2CA7CA9
SCHEMBL4262832 0.86 TSHR (0.65) CA12CA1CA2CA7CA9
SCHEMBL5788119 0.86 ALDH1A1 (0.68) CA12CA1CA2CA7CA9
SCHEMBL1235309 0.85 CA12 (0.67) CA12CA1CA2CA7CA9
SCHEMBL1242911 0.85 GAA (0.66) CA12CA1CA2CA7CA9
Ethyl Salicylate SCHEMBL39622 0.85 TSHR (0.77) CA12CA1CA2CA7CA9
SCHEMBL7775643 0.85 TDP1 (0.61) CA12CA1CA2CA7CA9
Ethyl Salicylate SCHEMBL1870434 0.85 TSHR (0.77) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3470464-B1 LAYER COMPOSITIONS WITH IMPROVED ELECTRICAL PARAMETERS COMPRISING PEDOT/PSS AND A STABILIZER HERAEUS EPURIO GMBH (DE) 2025-10-29 EP claimed
US-20210403985-A1 PHOTOPROTECTIVE MIXTURES AS IMAGING REAGENTS IN SEQUENCING-BY-SYNTHESIS QIAGEN SCIENCES, LLC 2021-12-30 US claimed
CN-113677319-A Increasing the stability of agents for treating keratin materials 汉高股份有限及两合公司 2021-11-19 CN claimed
US-11162129-B2 Photoprotective mixtures as imaging reagents in sequencing-by-synthesis IsoPlexis Corporation (US) 2021-11-02 US claimed
EP-3538093-A1 PHOTOPROTECTIVE MIXTURES AS IMAGING REAGENTS IN SEQUENCING-BY-SYNTHESIS Qiagen Sciences, LLC (US) 2019-09-18 EP claimed
EP-3470464-A1 LAYER COMPOSITIONS WITH IMPROVED ELECTRICAL PARAMETERS COMPRISING PEDOT/PSS AND A STABILIZER Heraeus Deutschland GmbH & Co KG (DE) 2019-04-17 EP claimed
WO-2018089231-A1 PHOTOPROTECTIVE MIXTURES AS IMAGING REAGENTS IN SEQUENCING-BY-SYNTHESIS QIAGEN SCIENCES LLC (US) 2018-05-17 WO claimed
US-20180127809-A1 Photoprotective Mixtures As Imaging Reagents In Sequencing-By-Synthesis IsoPlexis Corporation 2018-05-10 US claimed
EP-1041448-B1 Method for decoloring TOSHIBA KK (JP) 2006-06-07 EP claimed
US-6326332-B1 HEATING KABUSHIKI KAISHA TOSHIBA (JP) 2001-12-04 US claimed
EP-1041448-A1 Decolorable material and method for decoloring the same Kabushiki Kaisha Toshiba (JP) 2000-10-04 EP claimed
US-12576055-B2 Disease detection and treatment based on trimethyl-lysine levels THE CLEVELAND CLINIC FOUNDATION (US) 2026-03-17 US disclosed
EP-3470464-B1 LAYER COMPOSITIONS WITH IMPROVED ELECTRICAL PARAMETERS COMPRISING PEDOT/PSS AND A STABILIZER HERAEUS EPURIO GMBH (DE) 2025-10-29 EP disclosed
WO-2024243289-A2 GUT MICROBE DERIVED AROMATIC AMINO ACID METABOLITES FOR DETECTION AND TREATMENT OF DISEASE THE CLEVELAND CLINIC FOUNDATION (US) 2024-11-28 WO disclosed
CN-115612699-B Copolymer membrane, and enzymatic self-assembly synthesis method and application thereof in gas-liquid interface 中国科学院天津工业生物技术研究所 2024-10-25 CN disclosed
EP-0643035-A1 DERMATOLOGIC PREPARATION AND NOVEL BENZOIC ACID DERIVATIVE Kao Corporation (JP) 1995-03-15 EP disclosed
EP-0643397-A1 Electrically conducting compositions NESTE OY (FI) 1995-03-15 EP disclosed
EP-0604494-A1 5-HT 4? RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-07-06 EP disclosed
WO-1993005038-A1 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-03-18 WO disclosed
US-4182918-A Process for the preparation of polyhydric phenols BAYER AKTIENGESELLSCHAFT (DE) 1980-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210403985-A1 PHOTOPROTECTIVE MIXTURES AS IMAGING REAGENTS IN SEQUENCING-BY-SYNTHESIS POLL, POLN, POLRMT CA12 3838/4885CA1 4213/4885CA2 3852/4885
US-12576055-B2 Disease detection and treatment based on trimethyl-lysine levels BHMT, BHMT2, EHMT2 CA12 1832/4885CA1 2402/4885CA2 1446/4885
US-11162129-B2 Photoprotective mixtures as imaging reagents in sequencing-by-synthesis POLL, POLN, POLRMT CA12 3838/4885CA1 4213/4885CA2 3852/4885
US-20180127809-A1 Photoprotective Mixtures As Imaging Reagents In Sequencing-By-Synthesis POLL, POLN, POLRMT CA12 3838/4885CA1 4213/4885CA2 3852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.